Jermann, M.; Jost, L. M.; Taverna, Ch.; Jacky, E.; Honegger, H. P.; Betticher, D. C.; Egli, F.; Kroner, Th.; Stahel, R. A. (2004). Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study. Annals of oncology, 15(3), pp. 511-516. Oxford University Press 10.1093/annonc/mdh093
|
Text
mdh093.pdf - Published Version Available under License Publisher holds Copyright. Download (228kB) | Preview |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Betticher, Daniel |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Markus Müller |
Date Deposited: |
01 Oct 2018 15:42 |
Last Modified: |
05 Dec 2022 15:13 |
Publisher DOI: |
10.1093/annonc/mdh093 |
BORIS DOI: |
10.7892/boris.115567 |
URI: |
https://boris.unibe.ch/id/eprint/115567 |
Actions (login required)
 |
Edit item |